Sectoral Asset Management Inc Affimed N.V. Transaction History

Sectoral Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.27 - $4.86 $153,225 - $328,050	-67,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.37 - $7.07 $120,825 - $159,075	22,500 Added 50.0%	67,500 $373,000
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $350,100 - $513,000	45,000 New	45,000 $383,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $178M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.